Clinical practice guideline for the management of infantile hemangiomas
This is the first clinical practice guideline (CPG) from the American Academy of Pediatrics
(AAP) regarding the management of infantile hemangiomas (IHs). Similar consensus …
(AAP) regarding the management of infantile hemangiomas (IHs). Similar consensus …
Infantile hemangioma. Part 2: management
The majority of infantile hemangiomas (IH) can be managed conservatively, but for those
requiring active treatment, management has been revolutionized in the last decade by the …
requiring active treatment, management has been revolutionized in the last decade by the …
[HTML][HTML] Update on infantile hemangioma
HL Jung - Clinical and experimental pediatrics, 2021 - ncbi.nlm.nih.gov
Abstract The International Society for the Study of Vascular Anomalies classifies vascular
anomalies into vascular tumors and vascular malformations. Vascular tumors are neoplasms …
anomalies into vascular tumors and vascular malformations. Vascular tumors are neoplasms …
Current treatment and management of infantile hemangiomas
KR Satterfield, CB Chambers - Survey of ophthalmology, 2019 - Elsevier
Infantile hemangiomas, otherwise known as infantile capillary hemangiomas, strawberry
hemangiomas, or strawberry nevi, are nonmalignant vascular tumors that commonly affect …
hemangiomas, or strawberry nevi, are nonmalignant vascular tumors that commonly affect …
[HTML][HTML] Progress in the treatment of infantile hemangioma
ZY Chen, QN Wang, YH Zhu, LY Zhou… - Annals of …, 2019 - ncbi.nlm.nih.gov
Infantile hemangioma (IH) is a common benign tumor, which mostly resolves spontaneously;
however, children with high-risk IH need treatment. Currently, the recognized first-line …
however, children with high-risk IH need treatment. Currently, the recognized first-line …
Infantile hemangioma: a review of current pharmacotherapy treatment and practice pearls
L Tiemann, S Hein - The Journal of Pediatric …, 2020 - meridian.allenpress.com
Infantile hemangioma (IH) is the most common vascular tumor of infancy, affecting as many
as 5% to 10% of all infants. The exact cause is unclear, but specific risk factors, such as low …
as 5% to 10% of all infants. The exact cause is unclear, but specific risk factors, such as low …
Rhodium (III)‐Catalyzed C‐H Activation of Benzoylacetonitriles and Cyclization with Sulfoxonium Ylides to Naphthols
C Zhou, F Fang, Y Cheng, Y Li, H Liu… - Advanced Synthesis & …, 2018 - Wiley Online Library
Abstract Rhodium (III)‐Catalyzed C− H activation of benzoylacetonitriles in coupling with
sulfoxonium ylides was developed to synthesize diversified substituted naphthols, in which …
sulfoxonium ylides was developed to synthesize diversified substituted naphthols, in which …
Management of infantile hemangiomas: Recent advances
W Xu, H Zhao - Frontiers in oncology, 2022 - frontiersin.org
Infantile hemangiomas (IHs) are benign vascular tumors commonly observed in children. A
small number of cases can manifest as organ or system dysfunction, permanent scarring, or …
small number of cases can manifest as organ or system dysfunction, permanent scarring, or …
Infantile hemangioma: an updated review
AKC Leung, JM Lam, KF Leong… - Current Pediatric …, 2021 - ingentaconnect.com
Background: Infantile hemangiomas are the most common vascular tumors of infancy,
affecting up to 12% of infants by the first year of life. Objective: To familiarize physicians with …
affecting up to 12% of infants by the first year of life. Objective: To familiarize physicians with …
Efficacy and adverse effects of oral propranolol in infantile hemangioma: a meta-analysis of comparative studies
H Yang, DL Hu, Q Shu, XD Guo - World Journal of Pediatrics, 2019 - Springer
Background A number of clinical trials evaluated the efficacy and adverse effects of oral
propranolol in the treatment of infantile hemangioma (IH), but the treatment has not yet been …
propranolol in the treatment of infantile hemangioma (IH), but the treatment has not yet been …